Navigation Links
Ferring Pharmaceuticals Inc. Announces $1M Donation to the Alliance for Fertility Preservation, a Newly Formed Charitable Organization
Date:6/3/2013

PARSIPPANY, N.J., June 3, 2013 /PRNewswire-USNewswire/ -- Today, Ferring Pharmaceuticals Inc. announced that it will donate $1M to the Alliance for Fertility Preservation (the Alliance), a newly formed 501c3 charitable organization established by and comprised of experts representing a broad range of disciplines. The Alliance helps to promote the education of patients diagnosed with cancer to enable them to make the best informed decisions regarding fertility preservation options prior to commencement of treatment and to better understand potential opportunities to help manage infertility after treatment.

According to survey responses from cancer survivors of childbearing age, less than half of patients recalled having a discussion of fertility or the effects their treatment might have on their future fertility upon being diagnosed with cancer.[i] Over 70,000 women in their twenties and thirties are diagnosed with various forms of cancer each year.[ii]

"As cancer survival rates increase, more and more patients need to consider their life after treatment, including how they might build or expand their family," said Joy Lewin , Director of Ferring's reproductive health unit. "Unfortunately, when faced with the overwhelming decisions surrounding their cancer diagnosis, future fertility is not top of mind.  We believe it's imperative to drive a better dialogue between healthcare providers and patients, which is why Ferring is supporting the Alliance in meeting this unmet need."

Formed in December 2011, the Alliance for Fertility Preservation, which was awarded 501c3 status on January 22, 2013 endeavors to promote a dialogue between patients and clinicians in an effort to optimize patient knowledge as to their expectations regarding fertility options as affected by their cancer care. The Alliance's unique, multidisciplinary approach with representation of experts in the fields of reproductive endocrinology, embryology, urology, oncology, psychology and reproductive law, will help the Alliance to address its goals.  

With the help provided by Ferring's donation, the Alliance will seek to develop educational tools to facilitate communication between patients and health care providers, work with healthcare systems to ensure they are equipped to provide patients with current and accurate information about fertility preservation and help to promote research in the field.

"Building on the American Society of Clinical Oncology's guidelines, the Alliance will work to identify different ways to assist physicians within different communities to help them educate their patients about fertility preservation and to provide support which enables patients to make informed decisions about their fertility options," said John Mulhall , M.D., Chairman of the Alliance for Fertility Preservation and urologist at Memorial Sloan Kettering Cancer Center.

Other members of the executive committee include:

  • Zev Rosenwaks, M.D., Alliance Vice Chairman, Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine at New York-Presbyterian Hospital/ Weill Cornell Medical Center
  • Glenn Schattman , M.D., Alliance Secretary/Treasurer, Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine at New York-Presbyterian Hospital/ Weill Cornell Medical Center
  • Leslie Schover , Ph.D., Alliance Executive Committee, University of Texas MD Anderson Cancer Center
  • Tessa Cigler , M.D., M.P.H., Alliance Executive Committee. Weill Cornell Medical College, Division of Medical Oncology

About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urologygastroenterologyendocrinology and osteoarthritis. For more information, visit www.ferringUSA.com.

About the Alliance for Fertility Preservation
The Alliance for Fertility Preservation was formed to help facilitate a dialogue between clinicians and patients who have recently been diagnosed with cancer in the U.S. about the potential loss of fertility due to cancer treatment and the options for fertility preservation. The mission of the Alliance for Fertility Preservation (the Alliance) is to educate and empower patients diagnosed with cancer to make the best decisions regarding fertility preservation prior to treatment and infertility management after treatment. The Alliance also endeavors to promote dialogue between patients and clinicians in an effort to optimize expectations and care. For more information, visit www.fertilitypreservationalliance.org or call 1-877-760-4122.

[i] Lee SJ, Schover LR, Patridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24(3): 2917-2931.

[ii] http://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=7616037&term=CA134197


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Extends Its Heart to Heart Video Contest
2. Ferring Pharmaceuticals Inc. Adopts Local Morristown Playground
3. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
4. Ferring to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting
5. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
6. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
7. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
8. Ampio Pharmaceuticals Provides Clinical Updates
9. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
10. Auxilium Pharmaceuticals, Inc. To Present At The Jefferies 2013 Healthcare Conference
11. Isis Pharmaceuticals Announces Exercise of Underwriters Option to Purchase Additional Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- Research and Markets has announced the ... 2016-2020" report to their offering.      ... global plastic surgery products market is expected to grow ... , ,The growing adoption of laser in aesthetics is ... market. Lasers are used to treat a broad range ...
(Date:4/28/2016)... , April 28, 2016  The blood testing ... million dollars, according to Kalorama Information and The Freedonia ... immunoassays and nucleic acid testing.  The healthcare research firm ... progress in developing blood collection stations and in improving ... in Kalorama Information,s report, Blood Testing Market ...
(Date:4/28/2016)... Dr. Vivek Ahuja , George ... phen Schmidt Join the Growing Organization ... for life sciences, today announced key new leaders have joined the ... a growing business.  This will bolster the company,s safety business unit ... ArisGlobal in the position of Vice President - Safety. George has ...
Breaking Medicine Technology:
(Date:4/30/2016)... ... 2016 , ... Saturday, April 30, marks World Veterinary Day, ... health. The World Veterinary Association (WVA) and the World Organization for Animal Health ... with a One Health focus, which emphasizes how veterinarians pursue continuing education opportunities ...
(Date:4/29/2016)... ... April 30, 2016 , ... World ... the Pick Up Springboard, an automotive invention that improves the storage features of ... worth $162 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... Sedona, Arizona (PRWEB) , ... April 29, 2016 ... ... Shamanic Healing and Spiritual Awakening , announces the addition Onnit brand Alpha BRAIN ... , The addition of Onnit brain and mood optimization products to the store ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White ... repaying their loans, more information about their loan terms and accounts, and more ... loan debt, including federal and private loans, has reached $1.3 trillion, with 43 ...
(Date:4/29/2016)... ... April 29, 2016 , ... The ... the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition ... Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making ...
Breaking Medicine News(10 mins):